758 related articles for article (PubMed ID: 20427691)
1. Central nervous system penetration for small molecule therapeutic agents does not increase in multiple sclerosis- and Alzheimer's disease-related animal models despite reported blood-brain barrier disruption.
Cheng Z; Zhang J; Liu H; Li Y; Zhao Y; Yang E
Drug Metab Dispos; 2010 Aug; 38(8):1355-61. PubMed ID: 20427691
[TBL] [Abstract][Full Text] [Related]
2. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
[TBL] [Abstract][Full Text] [Related]
3. Spatial diversity of blood-brain barrier alteration and macrophage invasion in experimental autoimmune encephalomyelitis: a comparative MRI study.
Ladewig G; Jestaedt L; Misselwitz B; Solymosi L; Toyka K; Bendszus M; Stoll G
Exp Neurol; 2009 Nov; 220(1):207-11. PubMed ID: 19733560
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the timing of acute blood-brain barrier breakdown to rabbit immunoglobulin G in the cerebellum and spinal cord of mice with experimental autoimmune encephalomyelitis.
Tonra JR; Reiseter BS; Kolbeck R; Nagashima K; Robertson R; Keyt B; Lindsay RM
J Comp Neurol; 2001 Jan; 430(1):131-44. PubMed ID: 11135250
[TBL] [Abstract][Full Text] [Related]
5. T-cell trafficking competence is required for CNS invasion.
Lees JR; Archambault AS; Russell JH
J Neuroimmunol; 2006 Aug; 177(1-2):1-10. PubMed ID: 16822552
[TBL] [Abstract][Full Text] [Related]
6. TET inducible expression of the α4β7-integrin ligand MAdCAM-1 on the blood-brain barrier does not influence the immunopathogenesis of experimental autoimmune encephalomyelitis.
Döring A; Pfeiffer F; Meier M; Dehouck B; Tauber S; Deutsch U; Engelhardt B
Eur J Immunol; 2011 Mar; 41(3):813-21. PubMed ID: 21341265
[TBL] [Abstract][Full Text] [Related]
7. Increased thrombin inhibition in experimental autoimmune encephalomyelitis.
Beilin O; Karussis DM; Korczyn AD; Gurwitz D; Aronovich R; Hantai D; Grigoriadis N; Mizrachi-Kol R; Chapman J
J Neurosci Res; 2005 Feb; 79(3):351-9. PubMed ID: 15605378
[TBL] [Abstract][Full Text] [Related]
8. Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme.
Wolburg H; Wolburg-Buchholz K; Kraus J; Rascher-Eggstein G; Liebner S; Hamm S; Duffner F; Grote EH; Risau W; Engelhardt B
Acta Neuropathol; 2003 Jun; 105(6):586-92. PubMed ID: 12734665
[TBL] [Abstract][Full Text] [Related]
9. CNS-irrelevant T-cells enter the brain, cause blood-brain barrier disruption but no glial pathology.
Smorodchenko A; Wuerfel J; Pohl EE; Vogt J; Tysiak E; Glumm R; Hendrix S; Nitsch R; Zipp F; Infante-Duarte C
Eur J Neurosci; 2007 Sep; 26(6):1387-98. PubMed ID: 17880383
[TBL] [Abstract][Full Text] [Related]
10. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
[TBL] [Abstract][Full Text] [Related]
11. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
[TBL] [Abstract][Full Text] [Related]
12. Immune-related GTPase Irgm1 exacerbates experimental auto-immune encephalomyelitis by promoting the disruption of blood-brain barrier and blood-cerebrospinal fluid barrier.
Wang C; Wang C; Dong H; Wu XM; Wang C; Xia F; Li G; Jia X; He S; Jiang X; Li H; Xu H
Mol Immunol; 2013 Jan; 53(1-2):43-51. PubMed ID: 22796503
[TBL] [Abstract][Full Text] [Related]
13. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.
Poduslo JF; Curran GL; Wengenack TM; Malester B; Duff K
Neurobiol Dis; 2001 Aug; 8(4):555-67. PubMed ID: 11493021
[TBL] [Abstract][Full Text] [Related]
14. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF
Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803
[TBL] [Abstract][Full Text] [Related]
15. Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis.
Matejuk A; Bakke AC; Hopke C; Dwyer J; Vandenbark AA; Offner H
J Neurosci Res; 2004 Jul; 77(1):119-26. PubMed ID: 15197745
[TBL] [Abstract][Full Text] [Related]
16. Blood-brain barrier permeation models: discriminating between potential CNS and non-CNS drugs including P-glycoprotein substrates.
Adenot M; Lahana R
J Chem Inf Comput Sci; 2004; 44(1):239-48. PubMed ID: 14741033
[TBL] [Abstract][Full Text] [Related]
17. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates experimental autoimmune encephalomyelitis via modulation of endothelial-monocyte interaction.
Prasad R; Giri S; Nath N; Singh I; Singh AK
J Neurosci Res; 2006 Aug; 84(3):614-25. PubMed ID: 16770773
[TBL] [Abstract][Full Text] [Related]
18. Role of Ninjurin-1 in the migration of myeloid cells to central nervous system inflammatory lesions.
Ifergan I; Kebir H; Terouz S; Alvarez JI; Lécuyer MA; Gendron S; Bourbonnière L; Dunay IR; Bouthillier A; Moumdjian R; Fontana A; Haqqani A; Klopstein A; Prinz M; López-Vales R; Birchler T; Prat A
Ann Neurol; 2011 Nov; 70(5):751-63. PubMed ID: 22162058
[TBL] [Abstract][Full Text] [Related]
19. Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis.
Foster CA; Howard LM; Schweitzer A; Persohn E; Hiestand PC; Balatoni B; Reuschel R; Beerli C; Schwartz M; Billich A
J Pharmacol Exp Ther; 2007 Nov; 323(2):469-75. PubMed ID: 17682127
[TBL] [Abstract][Full Text] [Related]
20. Endothelial Wnt/β-catenin signaling reduces immune cell infiltration in multiple sclerosis.
Lengfeld JE; Lutz SE; Smith JR; Diaconu C; Scott C; Kofman SB; Choi C; Walsh CM; Raine CS; Agalliu I; Agalliu D
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):E1168-E1177. PubMed ID: 28137846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
